We also confirmed that JQ1 markedly reduced the expression levels of the RUNX2 and MYC proteins in CAL-1 cells, while Jurkat T-ALL cells showed a mild change in MYC protein levels after the JQ1 treatment (Fig. 4b). Here, MYC is linked to acute lymphoblastic leukemia.